Real-world data to support early patient
identification for patients with neurodegenerative and behavioral
health diseases.
NEW
YORK, Jan. 24, 2024 /PRNewswire/ -- LANGaware,
an innovative leader in digital cognitive and behavioral health
diagnostics, is announcing that it will partner with Premier's
(NASDAQ: PINC) PINC AI™ Applied Sciences (PAS) to leverage
Real-World Data (RWD) for the development of novel therapeutics
addressing neurodegenerative and behavioral health diseases.
PAS, renowned for its robust data gleaned from over 4,350
hospitals and 300,000 continuum-of-care providers nationwide, will
provide expertise in conducting prospective research utilizing
retrospective synthetic arms built from the PINC AI™ Healthcare
Database (PHD).
"Neurodegenerative diseases like Alzheimer's and Parkinson's and
behavioral health conditions such as depression affect millions of
people worldwide," said Denise
Juliano, Group Vice President of Life Sciences at PINC AI™
Applied Sciences. "The PAS-LANGaware partnership will enable RWD
that supports early patient identification and detection – and
drives evidence-based decisions by clinicians to improve quality,
lower costs, reduce risk and help ensure safety for these
patients."
LANGaware, known for its AI-driven precision in early detection,
aims to extend the availability of its platform to individuals,
health systems and life science companies. Through unique voice and
language biomarkers, LANGaware's technology reduces the likelihood
of false positives and unnecessary treatments.
"We are thrilled to partner with PAS and extend the reach of our
digital assessment tool to more patients, health systems and life
science companies," said Vassiliki Rentoumi, Founder and CEO of
LANGaware. "Our goal is to revolutionize early detection of
cognitive and mental health diseases, supporting novel therapy
development as well as earlier intervention by providers, to
improve patient outcomes and drive positive changes in the
healthcare industry. We are actively seeking partners that share
our commitment to transforming patient care."
The collaboration signifies a significant step forward in
expanding access to advanced diagnostic services across
the United States. By combining
PAS' extensive network of health systems and PINC AI's RWD
capabilities with LANGaware's cutting-edge technology, the
partnership aims to revolutionize healthcare by driving innovation
in early detection and treatment.
About LANGaware
LANGaware is a pioneering company that
leverages AI technology to revolutionize cognitive and mental
health diagnostics. By utilizing speech analysis and proprietary
voice and speech biomarkers, LANGaware provides early and objective
detection of conditions, enabling more effective treatments,
reducing healthcare burdens, and improving overall well-being. The
company's vision is to transform the healthcare industry by
seamlessly integrating AI-driven diagnostic tools and empowering
healthcare professionals with valuable insights for personalized
care. For more information, please visit LANGaware's In the News on
www.langaware.com; as well as Twitter,
LinkedIn, and LANGaware's blog for more information
about the company.
About PINC AI™ Applied Sciences (PAS)
PAS is a trusted
leader in accelerating healthcare improvement through services,
data and scalable solutions, spanning the continuum of care and
enabling sustainable innovation and rigorous research. These
services and RWD are valuable resources for the pharmaceutical,
device and diagnostic industries, academia, federal and national
healthcare agencies, as well as hospitals and health systems. Since
2000, PAS researchers have produced more than 1,000 publications
which appear in 264 scholarly, peer-reviewed journals, covering a
wide variety of topics, and conduct population-based analyses of
drugs, devices, treatments, disease states, epidemiology, resource
utilization, healthcare economics and clinical outcomes.
About the PINC AI™ Platform
PINC
AI™ is the technology and services platform
of Premier, Inc. (NASDAQ: PINC). With more than 20 years'
worth of cost, quality and operational data gleaned from 45 percent
of U.S. hospital discharges, 2.7 billion hospital outpatient and
clinic encounters and 177 million physician office visits, the PINC
AI™ platform provides actionable intelligence to help
improve outcomes, support improved financial performance and enable
success in new, alternative payment models. PINC
AI™ offerings and capabilities can be followed
on Twitter and LinkedIn.
Premier, Inc. Forward-Looking Statements
This press
release includes statements about Premier and PINC AI™ and the use
of their products and services that are not statements of
historical or current facts and are "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements may involve known and unknown
risks, uncertainties and other factors that may cause performance
or achievements relating to Premier and PINC AI products and
services to be materially different from any future results or
projections expressed or implied by such forward-looking
statements. Accordingly, readers should not place undue reliance on
any forward-looking statements. More information on potential risk
factors relating to Premier and PINC AI is included from time to
time in the "Cautionary Note Regarding Forward-Looking Statements,"
"Risk Factors" and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" sections of
Premier's periodic and current filings with the SEC, which are also
made available on Premier's website at
investors.premierinc.com.
Media Contacts:
|
|
Virginia Korma
|
Sarah
Flora
|
646-878-9063
|
913-683-4015
|
virginia@langaware.com
|
sarah@langaware.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/langaware-forges-transformative-collaboration-with-premier-incs-pinc-ai-applied-sciences-pas-to-revolutionize-healthcare-302040964.html
SOURCE LANGaware